BiotechnologyEconomic TimesWednesday, January 14, 2015http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/…MUMBAI: India's patent office has rejected an application from US-based Gilead Sciences Inc for its hepatitis C drug Sovaldi, ….
